Company Long-Term Loans and Borrowings: Sage Therapeutics, Inc (SAGE)
The market dynamics of Sage Therapeutics, Inc. (SAGE) reflected in the price action demonstrate a long-term debt structure amounting to 0.01. The company's revenues rely on the recognition of its products by insurance companies and physicians. Exclusive patents and industry influence under strict FDA control serve as business protections. The firm is currently optimizing its workforce following failed tests, retaining key specialists through stock option programs.
Sage Therapeutics, Inc (SAGE) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Total Debt to Capital Sage Therapeutics, Inc.|SAGE - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Sage Therapeutics Inc|SAGE - Company Aggregate Debts|Debts to Book Value Sage Therapeutics|SAGE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Sage Therapeutics|Intermediate Liquidity Ratio sagerx.com
- earnings and market multiples details:
Summary company analytics:Sage Therapeutics, Inc.
Sage Therapeutics, Inc. (SAGE) holds unique psychiatric patents that ensure high market protection. Analyzing the business's current level of long-term debt allows for an assessment of the company's financial stability. This metric aggregates all confirmed obligations with maturities exceeding one year, revealing the overall credit burden. Under strict FDA regulation, borrowings often fund protracted clinical trials. Debt dynamics enable investors to weigh drug development costs against debt risks.
Competitor analysis for Sage Therapeutics, Inc.
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|vikingtherapeutics.com (VKTX) - Long-Term Debt Volume|Company Long-Term Debts SUPN|Company Long-Term Debts Catalyst Pharma (CPRX)|Company Long-Term Debts DNLI (Denali Therapeutics Inc)|Long-Term Indebtedness Harmony Corp|Biohaven Ltd. - Company Long-Term Debts|Long-Term Debt amylyx.com|TRVI (Trevi Therapeutics, Inc.) - Company Long-Term Liabilities|Praxis Precision Medicines Inc - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities AVXL|CBLL (CeriBell EEG) - Amount of Long-Term Liabilities|Company Long-Term Debts PRTA|ALEC (alector.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ANNX (Annexon)|Omeros Corp (OMER) - Long-Term Debt|NGNE - Company Long-Term Debt|Company Long-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Long-Term Debts|neumoratx.com (NMRA) - Company Long-Term Debts|Company Long-Term Debt Scilex|Tevogen Bio Holdings Inc. - Long-Term Liabilities|Company Long-Term Debts ACOG|CGTX - Long-Term Debt|Inhibikase Therapeutics - Company Long-Term Liabilities|Company Long-Term Debts cassavasciences.com SAVA|ASRT: Company Long-Term Liabilities|Coya Therapeutics, Inc. - Amount of Long-Term Liabilities|VTGN: Company Long-Term Debts|OVID - Long-Term Debt Volume|ABOS (Acumen Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Liabilities cervomed.com (CRVO)|Company Long-Term Debt Alterity Therapeutics (ATHE)|Long-Term Debt Volume clene.com|PepGen - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings JUNS|Relmada Therapeutics - Company Long-Term Debts|Long-Term Debt Volume annovisbio.com ANVS|gracetx.com (GRCE) - Company Long-Term Debt|Company Long-Term Indebtedness AIFF|KLTO (ANEW Medical) - Company Long-Term Debts|Company Long-Term Liabilities NeuroSense Therapeutics, Ltd. (NRSN)|Company Long-Term Liabilities RVPH (Reviva Pharmaceuticals)|Long-Term Debt Volume metaviatx.com|Company Long-Term Debt NeurAxis NRXS|Long-Term Debt Volume Helius Medical Technologies, Inc. (HSDT)|Passage Bio Corp - Company Long-Term Debts|NEUP - Company Long-Term Debts|NERV: Company Long-Term Debts|Long-Term Indebtedness athira.com ATHA|ADXN (Addex Therapeutics Ltd) - Company Long-Term Debts|Long-Term Debt Alzamend ALZN|Company Long-Term Debt Cyclerion Therapeutics (CYCN)|protagenic.com - Company Long-Term Indebtedness|Company Long-Term Debts KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Long-Term Debt|ATXI: Company Long-Term Liabilities|BCLI - Company Long-Term Debts|Cara Therapeutics, Inc (CARA) - Company Long-Term Debt|Chromocell - Company Long-Term Loans and Borrowings|Company Long-Term Debt Eliem Therapeutics, Inc.|Long-Term Debt Intra-Cellular ITCI|Company Long-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Long-Term Debt Volume Marinus Pharmaceuticals Inc|Company Long-Term Debts NKGN (NKGen)|Company Long-Term Debts NeuroBo Pharma NRBO|Synaptogenix, Inc. - Company Long-Term Debts|Long-Term Indebtedness trevena.com (TRVN)|VIGL: Company Long-Term Debts|Long-Term Debt Anew Medical Inc. (WENA)|Company Long-Term Liabilities CERE